Publikace
- Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy2016 | 2. lékařská fakulta
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications2016 | 2. lékařská fakulta
- Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications2015 | 2. lékařská fakulta
- Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs2014 | 2. lékařská fakulta, Ústřední knihovna
- Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy2013 | 2. lékařská fakulta
- Type I interferon and cancer2024 | 2. lékařská fakulta
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | 1. lékařská fakulta, 2. lékařská fakulta, Lékařská fakulta v Plzni
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma2023 | 1. lékařská fakulta, 2. lékařská fakulta
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | 2. lékařská fakulta
- Interferon signaling restrains renal cell carcinoma heterogeneity2023 | 2. lékařská fakulta
Loading network view...